Pediatric Eye Disease Investigator Group (PEDIG)

Protocol: MTS1 - Low-Dose Atropine for Prevention of Myopia
Status: Upcoming
Start Date: 12/31/2017
End Date:  
Clinical Trial ID:  
Public Dataset:  

MTS1 - Low-Dose Atropine for Prevention of Myopia

 Protocol

The objectives for this randomized trial are:

  1. To determine the efficacy of daily low-dose atropine (0.01%) for slowing myopia progression over a two-year treatment period in children aged 5 to less than 13 years with myopia -1.00 to -6.00D at the time of enrollment (Primary Outcome On-Treatment).
  2. To determine the efficacy of atropine treatment on myopia progression 6 months following cessation of low-dose atropine treatment (Secondary Outcome Off-Treatment).

 

 



Back

© 2007 -2017 Jaeb Center for Health Research
All forms and reports on this site require Adobe Acrobat Reader. Click HERE to download a free copy of Adobe.
Although JCHR supports various web browsers, only Internet Explorer version 11 is fully tested and validated to function on this site.
This site utilizes popup windows.